CannBioRx Life Sciences Corp Cash Flow-to-Debt Ratio
CannBioRx Life Sciences Corp cash flow-to-debt ratio. CannBioRx Life Sciences Corp (ATNFW) has a Cash Flow-to-Debt Ratio of -0.21x as of June 2025, meaning its operating cash flow of $-1.13 Million could theoretically repay 0% of its total liabilities ($5.33 Million) in one year. Check ATNFW cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of CannBioRx Life Sciences Corp (2017–2024)
Cash flow-to-debt ratio of CannBioRx Life Sciences Corp from 2017 to 2024. Historical debt coverage capacity for CannBioRx Life Sciences Corp across 8 annual periods. Check CannBioRx Life Sciences Corp total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
CannBioRx Life Sciences Corp Cash Flow-to-Debt Ratio by Year (2017–2024)
CannBioRx Life Sciences Corp cash flow-to-debt ratio by year from 2017 to 2024. Year-by-year debt coverage analysis for CannBioRx Life Sciences Corp. For the full cash flow conversion analysis, see ATNFW cash flow metrics.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.42x | $-1.48 Million | $3.51 Million | ▲ +79.2% |
| 2023 | -2.03x | $-10.92 Million | $5.39 Million | ▼ -38.9% |
| 2022 | -1.46x | $-12.13 Million | $8.31 Million | ▼ -782.0% |
| 2021 | -0.17x | $-3.87 Million | $23.39 Million | ▼ -7.9% |
| 2020 | -0.15x | $-3.87 Million | $25.25 Million | ▲ +38.5% |
| 2019 | -0.25x | $-3.32 Million | $13.31 Million | ▼ -44.4% |
| 2018 | -0.17x | $-789.23K | $4.57 Million | ▼ -47.0% |
| 2017 | -0.12x | $-497.36K | $4.23 Million | — |